526075
VINRKLB
Start SIP
Invest Now
Start SIP in VINRKLB
Performance
- Low
- ₹23
- High
- ₹23
- 52 Week Low
- ₹7
- 52 Week High
- ₹23
- Open Price₹23
- Previous Close₹23
- Volume4,485
- 50 DMA₹11.84
- 100 DMA₹8.95
- 200 DMA₹7.66
Investment Returns
- Over 1 Month + 197.18%
- Over 3 Month + 415.11%
- Over 6 Month + 415.11%
- Over 1 Year + 415.11%
Smart Investing Starts Here Start SIP with Rekvina Laboratories for Steady Growth!
Rekvina Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -59
- PEG Ratio
- 0.4
- Market Cap Cr
- 14
- P/B Ratio
- -18.6
- Average True Range
- 0.63
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 3.6
- RSI
- 98.86
- MFI
- 100
Rekvina Laboratories Financials
Rekvina Laboratories Technicals
EMA & SMA
Current Price
₹23.18
+
0.44
(1.93%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹17.03
- 50 Day
- ₹11.84
- 100 Day
- ₹8.95
- 200 Day
- ₹7.66
Resistance and Support
23.18
- R3 23.20
- R2 23.19
- R1 23.19
- S1 23.18
- S2 23.17
- S3 23.17
Rekvina Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-06 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | (Revised) |
| 2025-05-30 | Audited Results | |
| 2025-01-20 | Quarterly Results |
Rekvina Laboratories F&O
About Rekvina Laboratories
- NSE Symbol
- VINRKLB
- BSE Symbol
- 526075
- Managing Director
- Mr. Amit Mukesh Shah
- ISIN
- INE092O01028
Similar Stocks to Rekvina Laboratories
Rekvina Laboratories FAQs
Rekvina Laboratories share price is ₹23 As on 17 February, 2026 | 22:40
The Market Cap of Rekvina Laboratories is ₹14 Cr As on 17 February, 2026 | 22:40
The P/E ratio of Rekvina Laboratories is -59 As on 17 February, 2026 | 22:40
The PB ratio of Rekvina Laboratories is -18.6 As on 17 February, 2026 | 22:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.